United States, Congress, House, Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
Label
United States, Congress, House, Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
Name
United States
Subordinate unit
CongressHouseCommittee on Energy and CommerceSubcommittee on Oversight and Investigations
Actions
Incoming Resources
- Nuclear Regulatory Commission, preliminary observations on its process to oversee the safe operations of nuclear power plants : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives, statement of Jim Wells
- Military and dual-use technology, covert testing shows continuing vulnerabilities of domestic sales for illegal export : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gregory D. Kutz
- Federal oversight of food safety, high-risk designation can bring attention to limitations in the government's food recall programs : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Lisa Shames
- Drug safety, FDA needs to further address shortcomings in its postmarket decision-making process : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Modernizing the nuclear security enterprise, observations on the National Nuclear Security Administration's oversight of safety, security, and project management : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Mark Gaffigan
- Cybersecurity, challenges in securing the modernized electricity grid : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gregory C. Wilshusen, David C. Trimble
- Drug safety: FDA has faced persistent challenges overseeing foreign drug manufacturing, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representative, statement of Mary Denigan-Macauley
- Bottled water, FDA safety and consumer protections are often less stringent than comparable EPA protections for tap water : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of John Stephenson
- Flu vaccine, recent supply shortages underscore ongoing challenges : testimony before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Janet Heinrich
- H1N1 preparedness, an overview of vaccine production and distribution : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, November 18, 2009
- Telecommunications, concerns regarding the structure and FCC's management of the E-rate program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Mark L. Goldstein
- Modernizing the nuclear security enterprise, observations on DOE's and NNSA's efforts to enhance oversight of security, safety, and project and contract management : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of David C. Trimble
- Securing U.S. nuclear materials, poor planning has complicated DOE's plutonium consolidation efforts : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gene Aloise
- Patients first, a 21st century promise to ensure quality and affordable health coverage : joint hearings before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, March 1, April 4, and May 10, 2001
- Medical devices, challenges for FDA in conducting manufacturer inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Internet pharmacies, most rogue sites operate from abroad, and many sell counterfeit drugs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Direct-to-consumer genetic tests, misleading test results are further complicated by deceptive marketing and other questionable practices : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gregory Kurtz
- Medicaid personal care services, more harmonized program requirements and better data are needed, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Katherine M. Iritani
- High-containment laboratories, recent incidents of biosafety lapses, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Nancy Kingsbury
- Medicare drug reimbursements, a broken system for patients and taxpayers : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, September 21, 2001
- Medicare fraud - further actions needed to address fraud, waste, and abuse, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Kathleen M. King
- Healthcare.gov, contract planning and oversight practices were ineffective given the challenges and risks, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of William T. Woods
- Combating nuclear smuggling, additional actions needed to ensure adequate testing of next generation radiation detection equipment : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gene Aloise, Keith Rhodes
- Prescription drugs, enhanced efforts and better agency coordination needed to address illegal importation : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives, statement of Richard M. Stana
- Medicare Advantage: continued monitoring and implementing GAO recommendations could improve oversight: testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Leslie V. Gordon
- Long-term care insurance, state oversight of rate setting and claims settlement practices : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of John E. Dicken
- Federal oversight of food safety, FDA's Food Protection Plan proposes positive first steps, but capacity to carry them out is critical : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Lisa Shames
- Department of Energy, observations on DOE's management challenges and steps taken to address them : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of David C. Trimble
- Federal oversight of food safety, FDA has provided few details on the resources and strategies needed to implement its Food Protection Plan : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Lisa Shames
- Antibiotic resistance: federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Mary Denigan-Macauley and Karen L. Howard ; United States Government Accountability Office
- High-containment laboratories, national strategy for oversight is needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Nancy Kingsbury
- Drug tests, products to defraud drug use screening tests are widely available : testimony before the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Robert J. Cramer
- Food safety, FDA could strengthen oversight of imported food by improving enforcement and seeking additional authorities : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Lisa Shames
- Patients first, a 21st century promise to ensure quality and affordable health coverage : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 28, 2001
- Department of Energy, budget trends and oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Frank Rusco
- Recovery Act, status of Department of Energy's obligations and spending : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Frank Rusco
- Broadband: a national strategy needed to coordinate fragmented, overlapping federal programs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Andrew Von Ah
- Pandemic origins, technologies, challenges, and policy options to support investigations : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Dr. Karen L. Howard
- Medicare, progress made to deter fraud, but more could be done : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Kathleen M. King
- Environmental Protection Agency, management challenges and budget observations : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of David C. Trimble
- Prescription drugs, trends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Nuclear material, several potential options for dealing with DOE's depleted uranium tails could benefit the government : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Robert A. Robinson
- Cybersecurity, continued attention needed to protect our nation's critical infrastructure : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gregory C. Wilshusen
- Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Influenza, progress made in responding to seasonal and pandemic outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Safeguards that need to accompany changes to Glass-Steagall laws, statement of Richard L. Fogel before the Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce, House of Representatives
- IT supply chain, additional efforts needed by national security-related agencies to address risks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gregory C. Wilshusen
- Nuclear security, Los Alamos National Laboratory faces challenges in sustaining physical and cyber security improvements : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Gene Aloise, Nabajyoti Barkakati, Gregory C. Wilshusen
- Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- High-containment biosafety laboratories, DHS lacks evidence to conclude that foot-and-mouth disease research can be done safely on the U.S. mainland : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Nancy Kingsbury, United States Government Accountability Office
- NASPER, why has the National All Schedules Prescription Electronic Reporting Act not been implemented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, October 24, 2007
- Confronting a growing public health threat, measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019
- Examining U.S. public health preparedness for and response efforts to seasonal influenza, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 8, 2018
- Protecting unaccompanied children, the ongoing impacts of the Trump administration's cruel policies : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
- Challenges facing America's businesses under the Patient Protection and Affordable Care Act, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, June 26, 2013
- Does HIPAA help or hinder patient care and public safety?, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 26, 2013
- Where have all the patients gone?, examining the psychiatric bed shortage : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, March 26, 2014
- A shot at normalcy, building COVID-19 vaccine confidence : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, May 26, 2021
- Germs, viruses, and secrets, the silent proliferation of bio-laboratories in the United States : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, October 4, 2007
- Poisoned patriots, contaminated drinking water at Camp Lejeune : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007
- Department of Energy oversight, status of loan programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, May 30, 2014
- A review of continuing security concerns at DOE's national laboratories, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, September 25, 2008
- Combating waste, fraud, and abuse in Medicaid's personal care services program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, May 2, 2017
- Identity verification in a post-breach world, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, November 30, 2017
- Undermining mercury protections, EPA endangers human health and the environment : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives. One Hundred Sixteenth Congress, first session, May 21, 2019
- Health insurance premiums under the Patient Protection and Affordable Care Act, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 20, 2013
- Outbreaks, attacks, and accidents, combating biological threats : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 12, 2016
- The role and performance of FDA in ensuring food safety, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, May 6, 2010
- Examining the impact of healthcare consolidation, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, February 14, 2018
- The federal green jobs agenda, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, June 19, 2012
- Cybersecurity in the healthcare sector, strengthening public-private partnerships : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, April 4, 2017
- Health care issues involving the Center for Consumer Information and Insurance Oversight, hearing before the Subcommittee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, February 16, 2011
- The fungal meningitis outbreak, could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012
- Direct-to-consumer advertising, marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008
- The federal response to COVID-19, joint hearing before the Subcommittee on Oversight and Investigations and the Subcommittee on Health of the Committee on Energy and Commerce, One Hundred Eighteenth Congress, first session, February 8, 2023
- The role of the Interior Department in the Deepwater Horizon disaster, joint hearing before the Subcommittee on Oversight and Investigations and the Subcommittee on Energy and Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, July 20, 2010
- The outbreak of salmonella in eggs, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, September 22, 2010
- Termination of individual health policies by insurance companies, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 16, 2009
- The views of the administration on regulatory reform, an update : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, June 3, 2011
- Protecting America's critical infrastructure, how secure are government computer systems? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, April 5, 2001
- Institutional review boards that oversee experimental human testing for profit, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 26, 2009
- Oversight and management of the government purchase card program, reviewing its weaknesses and identifying solutions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, May 1, 2002
- Examining the U.S. public health response to the Zika virus, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, March 2, 2016
- What is the federal government doing to combat the opioid abuse epidemic?, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, May 1, 2015
- Diminished capacity, can the FDA assure the safety and security of the nation's food supply? : Hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session
- Leading the way forward, Biden administration actions to increase COVID-19 vaccinations : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, March 17, 2021
- Sabotage: the Trump administration's attack on healthcare, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 23, 2019
- Continuing concerns with the Federal Select Agent Program, Department of Defense shipments of live anthrax : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, July 28, 2015
- Continuing concerns over BioWatch and the surveillance of bioterrorism, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, June 18, 2013
- Energy speculation, is greater regulation necessary to stop price manipulation? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress
- In the hands of strangers, are nursing home safeguards working? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 15, 2008
- Understanding the cyber threat and implications for the 21st century economy, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 3, 2016
- Patient Protection and Affordable Care Act, implementation in the wake of administrative delay : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 18, 2013
- Nuclear terrorism prevention, status report on the federal government's assessment of new radiation detection monitors : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, September 18, 2007
- The 2006 Prudhoe Bay shutdown, will recent regulatory changes and BP management reforms prevent future failures? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 16, 2007
- Department of Energy's FreedomCAR, hurdles, benchmarks for progress, and role in energy policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 6, 2002
- Department of Energy oversight, status of clean coal programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 11, 2014
- PPACA implementation, updates from CMS and GAO : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 31, 2014
- Cutting EPA spending, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, October 12, 2011
- Issues concerning the use of MTBE in reformulated gasoline, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, November 1, 2001
- Safety of the U.S. food supply, continuing concerns over the Food and Drug Administration's food-recall process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 19, 2018
- Confronting a growing public health threat, measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019
- Health information technologies, administration perspectives on innovation and regulation : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, one Hundred Thirteenth Congress, first session, March 21, 2013
- Examining U.S. public health preparedness for and response efforts to seasonal influenza, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 8, 2018
- Examining advertising and marketing practices within the substance use treatment industry, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 24, 2018
- Examining the Olympic community's ability to protect athletes from sexual abuse, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth congress, second session, May 23, 2018
- Identity verification in a post-breach world, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, November 30, 2017
- Combating waste, fraud, and abuse in Medicaid's personal care services program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, May 2, 2017
- Outbreaks, attacks, and accidents, combating biological threats : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 12, 2016
- Health insurance premiums under the Patient Protection and Affordable Care Act, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 20, 2013
- The federal green jobs agenda, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, June 19, 2012
- Examining the impact of healthcare consolidation, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, February 14, 2018
- The role and performance of FDA in ensuring food safety, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, May 6, 2010
- Undermining mercury protections, EPA endangers human health and the environment : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives. One Hundred Sixteenth Congress, first session, May 21, 2019
- The role of the Interior Department in the Deepwater Horizon disaster, joint hearing before the Subcommittee on Oversight and Investigations and the Subcommittee on Energy and Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, July 20, 2010
- Protecting America's critical infrastructure, how secure are government computer systems? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, April 5, 2001
- The outbreak of salmonella in eggs, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, September 22, 2010
- The federal response to COVID-19, joint hearing before the Subcommittee on Oversight and Investigations and the Subcommittee on Health of the Committee on Energy and Commerce, One Hundred Eighteenth Congress, first session, February 8, 2023
- The fungal meningitis outbreak, could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012
- Cybersecurity in the healthcare sector, strengthening public-private partnerships : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, April 4, 2017
- Understanding the cyber threat and implications for the 21st century economy, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 3, 2016
- Patient Protection and Affordable Care Act, implementation in the wake of administrative delay : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 18, 2013
- Oversight and management of the government purchase card program, reviewing its weaknesses and identifying solutions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, May 1, 2002
- What is the federal government doing to combat the opioid abuse epidemic?, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, May 1, 2015
- Continuing concerns over BioWatch and the surveillance of bioterrorism, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, June 18, 2013
- Department of Energy's FreedomCAR, hurdles, benchmarks for progress, and role in energy policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 6, 2002
- Department of Energy oversight, status of clean coal programs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 11, 2014
- Issues concerning the use of MTBE in reformulated gasoline, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, November 1, 2001
- Sabotage: the Trump administration's attack on healthcare, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 23, 2019
- Examining the U.S. public health response to the Zika virus, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, March 2, 2016
- Leading the way forward, Biden administration actions to increase COVID-19 vaccinations : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, March 17, 2021
- Continuing concerns with the Federal Select Agent Program, Department of Defense shipments of live anthrax : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, July 28, 2015
- PPACA implementation, updates from CMS and GAO : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 31, 2014
- Update on the U.S. public health response to the Ebola outbreak, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, November 18, 2014
- Direct-to-consumer genetic testing and the consequences to the public health, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, July 22, 2010
- Protecting communities from industrial accidents, revitalizing the Chemical Safety Board : hybrid hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, September 29, 2021
- Volkswagen's emissions cheating allegations, initial questions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, October 8, 2015
- An overdue checkup, examining the ACA's state insurance marketplaces : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session
- The ACA's cost sharing reduction program, ramifications of the administration's decision on the source of funding for the CSR program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, July 8, 2016
- Crib safety, assessing the need for better oversight : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, January 21, 2010
- The impact of patent assertion entities on innovation and the economy, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, November 14, 2013
- Medicare program integrity, screening out errors, fraud, and abuse : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, June 25, 2014
- Examining the U.S. public health response to seasonal influenza, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, February 3, 2015
- A review of federal bioterrorism preparedness programs from a public health perspective, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, October 10, 2001
- A humane response, prioritizing the well-being of unaccompanied children : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, June 9, 2021
- Continuing developments regarding the Solyndra loan guarantee, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, October 14, 2011
- Examining HRSA's oversight of the 340B Drug Pricing Program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017
- Examining the growing problems of prescription drug and heroin abuse, state and local perspectives : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 26, 2015
- Examining how covered entities utilize the 340B drug pricing program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017
- Power struggle, examining the 2021 Texas grid failure : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, March 24, 2021
- inverse.issuingbody1
- inverse.sponsoringbody16
- Drug safety: FDA has faced persistent challenges overseeing foreign drug manufacturing, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representative, statement of Mary Denigan-Macauley
- Modernizing the nuclear security enterprise, observations on DOE's and NNSA's efforts to enhance oversight of security, safety, and project and contract management : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of David C. Trimble
- Internet pharmacies, most rogue sites operate from abroad, and many sell counterfeit drugs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Medicaid personal care services, more harmonized program requirements and better data are needed, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Katherine M. Iritani
- High-containment laboratories, recent incidents of biosafety lapses, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Nancy Kingsbury
- Healthcare.gov, contract planning and oversight practices were ineffective given the challenges and risks, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of William T. Woods
- Medicare fraud - further actions needed to address fraud, waste, and abuse, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Kathleen M. King
- Department of Energy, observations on DOE's management challenges and steps taken to address them : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of David C. Trimble
- Antibiotic resistance: federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Mary Denigan-Macauley and Karen L. Howard ; United States Government Accountability Office
- Pandemic origins, technologies, challenges, and policy options to support investigations : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Dr. Karen L. Howard
- Broadband: a national strategy needed to coordinate fragmented, overlapping federal programs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Andrew Von Ah
- Safeguards that need to accompany changes to Glass-Steagall laws, statement of Richard L. Fogel before the Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce, House of Representatives
- Influenza, progress made in responding to seasonal and pandemic outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Medicare program, continued action required to address weaknesses in provider and supplier enrollment controls, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Seto J. Bagdoyan
- Intellectual property, insights gained from efforts to quantify the effects of counterfeit and pirated goods in the U.S. economy : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Susan Offutt
- Oversight of agency spending, implementing GAO recommendations could help address previously identified challenges at Commerce, DOE, and EPA : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Mark Gaffigan